Zhou W - Search Results

1

EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p.

Yi J, Ye Z, Xu H, Zhang H, Cao H, Li X, Wang T, Dong C, Du Y, Dong S, Zhou W. Yi J, et al. Among authors: zhou w. Phytomedicine. 2024 Dec;135:156137. doi: 10.1016/j.phymed.2024.156137. Epub 2024 Oct 19. Phytomedicine. 2024. PMID: 39566403

2

Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy.

Zhang JQ, Li YM, Liu T, He WT, Chen YT, Chen XH, Li X, Zhou WC, Yi JF, Ren ZJ. Zhang JQ, et al. World J Gastroenterol. 2010 Sep 14;16(34):4281-90. doi: 10.3748/wjg.v16.i34.4281. World J Gastroenterol. 2010. PMID: 20818811 Free PMC article.

3

Mn-SOD and CuZn-SOD polymorphisms and interactions with risk factors in gastric cancer.

Yi JF, Li YM, Liu T, He WT, Li X, Zhou WC, Kang SL, Zeng XT, Zhang JQ. Yi JF, et al. World J Gastroenterol. 2010 Oct 7;16(37):4738-46. doi: 10.3748/wjg.v16.i37.4738. World J Gastroenterol. 2010. PMID: 20872977 Free PMC article.

4

Cyclooxygenase-2 -765 G/C polymorphisms and susceptibility to hepatitis B-related liver cancer in Han Chinese population.

He J, Zhang Q, Ren Z, Li Y, Li X, Zhou W, Zhang H, Meng W, Yan J, He W. He J, et al. Among authors: zhou w. Mol Biol Rep. 2012 Apr;39(4):4163-8. doi: 10.1007/s11033-011-1199-y. Epub 2011 Jul 29. Mol Biol Rep. 2012. PMID: 21800055

5

Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases.

Zhou W, Li Y, Zhang Q, Li X, Meng W, Zhang L, Zhang H, Zhu K, Zhu X. Zhou W, et al. Pancreatology. 2011;11(4):399-405. doi: 10.1016/S1424-3903(11)80094-3. Epub 2011 Aug 31. Pancreatology. 2011. PMID: 21894057 Review.

6

Therapeutic effects of endoscopic therapy combined with enteral nutrition on acute severe biliary pancreatitis.

Zhou WC, Li YM, Zhang H, Li X, Zhang L, Meng WB, Zhu KX, Zhang QB, He MY. Zhou WC, et al. Chin Med J (Engl). 2011 Oct;124(19):2993-6. Chin Med J (Engl). 2011. PMID: 22040542

7

Cyclooxygenase-2 promoter polymorphism -899G/C is associated with hepatitis B-related liver cancer in a Chinese population of Gansu province.

He JH, Li YM, Zhang QB, Ren ZJ, Li X, Zhou WC, Zhang H, Meng WB, He WT. He JH, et al. Chin Med J (Engl). 2011 Dec;124(24):4193-7. Chin Med J (Engl). 2011. PMID: 22340386

8

Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell.

Meng W, Li X, Bai Z, Li Y, Yuan J, Liu T, Yan J, Zhou W, Zhu K, Zhang H, Li Y. Meng W, et al. Among authors: zhou w. PLoS One. 2014 Feb 28;9(2):e90660. doi: 10.1371/journal.pone.0090660. eCollection 2014. PLoS One. 2014. Retraction in: PLoS One. 2020 Dec 31;15(12):e0244942. doi: 10.1371/journal.pone.0244942 PMID: 24587407 Free PMC article. Retracted.

9

Combination of anti-angiogenesis agents and transarterial embolization: Is it a promising approach for the treatment of liver cancer?

Wang Z, Zhou W, Zhang H, Qiao L. Wang Z, et al. Among authors: zhou w. Discov Med. 2015 Jul-Aug;20(108):51-5. Discov Med. 2015. PMID: 26321087 Free article. Review.

10

Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy.

Rui S, Yan J, Zhang H, Wang Z, Zhou W. Rui S, et al. Among authors: zhou w. Medicine (Baltimore). 2017 Jul;96(30):e7608. doi: 10.1097/MD.0000000000007608. Medicine (Baltimore). 2017. PMID: 28746212 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,081 results

Search Page

Filters